摘要
目的比较以阳离子脂质体载体(DOTAP/cholesterol)介导的β1肾上腺素能受体反义寡核苷酸(β1-ASODN)与卡维地洛(Carvedilol)对核因子κB(NF-κB)、单核细胞趋化蛋白-1(MCP-1)在自发性高血压大鼠(SHR)大血管中表达的影响,探讨其对血管的保护机制。方法18只雄性12周龄SHR随机分为反义(ASODN)组(n=6,尾静脉注射β1-ASODN1.0mg/kg每2周一次,共4次);反向(INODN)组(n=6,尾静脉注射β1-INODN1.0mg/kg,每2周一次,共4次),Carvedilol组(n=6,30mg/(kg.d),灌喂8周)。用免疫组化测各组主动脉NF-κB、MCP-1的表达,ELISA法测血清MCP-1含量。结果8周后,INODN组与ASODN组和Carvedilol组比较,血压均有明显差异(P<0.01),NF-κB、MCP-1表达和血清MCP-1含量增加(P<0.01)。ASODN组与Carvedilol组之间血压无明显差异(P>0.05),主动脉组织中NF-κB、MCP-1表达和血清MCP-1含量两组之间无明显差异(P>0.05)。结论β1-ASODN具有持久的降压作用,并具有降压外对高血压大鼠主动脉的保护作用。
Objective To test the inhibitory ability of antisense oligonucleotides against rat β1-adrenergic receptor (β1-AR) mRNA (β1-ASODN) on the expression of NF-κB and MCP-1 in the aortic tissue of spontaneously hypertensive rats(SHRs). Methods Twelve-week-old male SHRs (n = 18) were randomly assigned to β1-ASODN group (n = 6), Carvedilol treated group (n = 6)and inverted oligonucleotides against rat β1-AR (β1-INODN) group(n = 6). SHRs of β1- ASODN group and β1-INODN group were treated via tail vein injection of β1-ASODN (1.0mg·kg^-1·14d^-1) and β1-INODN ( 1.0mg·kg^-1·14d^-1 ) respectively for 8 weeks. Rats in Carvedilol treated group were given a daily dose of 30mg/kg Carvedilol for 8 weeks by gavage. NF-κB and MCP-1 were examined by immunohistochemistry and serum MCP-1 concentrations were assayed by ELISA. Results After 8 weeks treatment, there was no significant difference of the expression of NF-κB and MCP-1 in the aorta, serum MCP-1 concentrations and the blood pressure level between β1-ASODN group and Carvedilol treated group(P〉0. 05). NF-κB and MCP-1 were significantly increased in the aorta of β1-INODN group compared with the treated groups(P〈0. 01). Conclusion Besides the consistent effect of decreasing blood pressure,β1- ASODN contributes to the early prevention and cure of the vascular complication of hypertension.
出处
《华南国防医学杂志》
CAS
2008年第2期47-49,共3页
Military Medical Journal of South China
基金
国家自然科学基金项目(30570729)